메뉴 건너뛰기




Volumn 18, Issue 10, 2010, Pages 3371-3378

Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives

Author keywords

4 Hydroxycoumarin; Anticoagulant; PIVKA II; Pyrazoles; Pyridines; Pyrimidines

Indexed keywords

1,2 DIHYDRO 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 2 OXO 4 (PYRIDINE 3 YL)PYRIDIN 3 CARBONITRILE; 1,2 DIHYDRO 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 4 (3,4,5 TRIMETHOXYPHENYL) 2 OXOPYRIDIN 3 CARBONITRILE; 2 AMINO 4 (FURAN 2 YL) 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)PYRIDIN 3 CARBONITRILE; 2 AMINO 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 4 (3,4,5 TRIMETHOXYPHENYL)PYRIDINE 3 CARBONITRILE; 3 [1 ACETYL 4,5 DIHYDRO 5 (PYRIDIN 3 YL) 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [1,2,5,6 TETRAHYDRO 6 (3,4,5 TRIMETHOXYPHENYL) 2 THIOXOPYRIMIDIN 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [1,2,5,6 TETRAHYDRO 6 (PYRIDIN 3 YL) 2 THIOXOPYRIMIDIN 4 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [4,5 DIHYDRO 1 PHENYL 5 (PYRIDIN 3 YL) 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [4,5 DIHYDRO 5 (3,4,5 TRIMETHOXYPHENYL) 1 PHENYL 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [4,5 DIHYDRO 5 (3,4,5 TRIMETHOXYPHENYL) 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [4,5 DIHYDRO 5 (4 METHOXYPHENYL) 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 3 [4,5 DIHYDRO 5 (PYRIDINE 3 YL) 1H PYRAZOL 3 YL] 4 HYDROXY 2H CHROMEN 2 ONE; 4 HYDROXYCOUMARIN DERIVATIVE; 4,5 DIHYDRO 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (3,4,5 TRIMETHOXYPHENYL) N PHENYLPYRAZOL 1 CARBOTHIOAMIDE; 4,5 DIHYDRO 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (4 METHOXYPHENYL) N PHENYLPYRAZOL 1 CARBOTHIOAMIDE; 4,5 DIHYDRO 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (4 METHOXYPHENYL)PYRAZOL 1 CARBOTHIOAMIDE; 4,5 DIHYDRO 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (PYRIDIN 3 YL)PYRAZOL 1 CARBOTHIOAMIDE; 4,5 DIHYDRO 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) N PHENYL 5 (PYRIDIN 3 YL)PYRAZOL 1 CARBOTHIOAMIDE; ANTICOAGULANT AGENT; DECARBOXYPROTHROMBIN; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; WARFARIN;

EID: 77953323133     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.04.009     Document Type: Article
Times cited : (136)

References (30)
  • 4
    • 77953321403 scopus 로고    scopus 로고
    • Numamoto, N.; Yamamoto, T.; Yamashita, A.; Hatano, T.; Kurahara, J. Jpn. Kokai Tokkyo Koho JP 02 36, 178 [90 36,178], (Cl C07 D311/46), 06 Feb 1990, Appl. 88/183,956, 22 Jul 1988, 5 p.
    • Numamoto, N.; Yamamoto, T.; Yamashita, A.; Hatano, T.; Kurahara, J. Jpn. Kokai Tokkyo Koho JP 02 36, 178 [90 36,178], (Cl C07 D311/46), 06 Feb 1990, Appl. 88/183,956, 22 Jul 1988, 5 p.
  • 5
    • 77953322475 scopus 로고    scopus 로고
    • LIPHA (Lyonnaise Industrielle Pharmaceutique), Brit. 1,252,088 (Cl. C07d, A61k, A01n), 03 Nov 1968, 11 p.
    • LIPHA (Lyonnaise Industrielle Pharmaceutique), Brit. 1,252,088 (Cl. C07d, A61k, A01n), 03 Nov 1968, 11 p.
  • 6
    • 77953323221 scopus 로고    scopus 로고
    • US 3 511 856 Cl 260-343.2, C07d, A01n, 12 May 1970, Appl. 24 Jun 1968, 3 p
    • McIntyre, J. S.; Knight, A. R. US 3 511 856 (Cl 260-343.2, C07d, A01n), 12 May 1970, Appl. 24 Jun 1968, 3 p.
    • McIntyre, J.S.1    Knight, A.R.2
  • 8
    • 77953324938 scopus 로고    scopus 로고
    • Whittle, A. J. Eur Pat Appl EP 175 466 (Cl C07D311/56), 26 Mar 1986, GB Appl 84/23,782, 20 Sep 1984, 7 p.
    • Whittle, A. J. Eur Pat Appl EP 175 466 (Cl C07D311/56), 26 Mar 1986, GB Appl 84/23,782, 20 Sep 1984, 7 p.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.